Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course

Journal of Infection and Chemotherapy

Volumn 13, Issue 5, 2007, Pages 343-345

  Nei, Takahito ^a,b   Saitoh, Takefumi ^b   Morimoto, Kouzo ^a,b,c   Watanabe, Kohichi ^b   Hayashihara, Kenji ^b   Azuma, Arata ^a   Kudoh, Shoji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Microbial substitution; Mycobacterium abscessus (MA); Mycobacterium avium intracellulare complex (MAI)

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; RIFAMPICIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE COURSE; FEMALE; HUMAN; LUNG INFECTION; LUNG TUBERCULOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRACTICE GUIDELINE; SPUTUM CULTURE;

EID: 35848939841     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-007-0545-4     Document Type: Article

References (4)

1. American Thoracic Society 1990 Diagnosis and treatment of disease caused by non-tuberculous mycobacteria Am Rev Respir Dis 142 940 53
2. DE Griffith T Aksamit BA Brown-Elliott A Catanzaro C Daley F Gordin 2007 An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Am J Respir Crit Care Med 175 367 416
3. E Tanaka T Kimoto K Tsuyuguchi K Suzuki R Amitani 2002 Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection J Infect Chemother 8 252 5
4. DE Griffith WM Girard RJ Wallace Jr 1993 Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients Am Rev Respir Dis 147 1271 8